Background and aims Lipid-modifying agents (LMAs) are increasingly used to reduce lipid
levels and prevent cardiovascular events but the magnitude of their consumption in different …

Introduction. The application of drugs in accordance with the marketing authorization issued
by the regulatory authority is considered on-label use, while off-label drug use frequently …

Background/Aim. Hypertension is one of the leading causes of cardiovascular morbidity and
mortality and more than a half of all health insurance expenditures for reimbursed medicines …

Abstract Objectives In the Czech Republic (CZ) extensive price regulation and prescribing
conditions are common instruments often employed with new drugs. Since the introduction …

Abstract Preclinical Research The development of new genomic technologies has led to an
exponential increase in the number of biomarkers for drug safety and efficacy …

Aims Given the discrepancies between PDDs (prescribed daily doses) and DDDs (defined
daily doses), we aimed to assess the extent of error in the results of an 18‐year population …

18F-fluorodeoxyglucose, being a radiolabeled glucose analogue, is a marker of glucose
metabolism indicator. Since glucose uptake is increased in malignant tumors, its major …

Introduction Cardiovascular diseases (CVD) are the most frequent cause of morbidity and
mortality in many countries as well as in our country. That explains why medications for the …

Pomoćna lekovita sredstva, gde bi spadale i gljive, mogu značajno da umanje rizik od
nastanka dijabetesa, da ga odlože ili da umanje njegove posledice. Pregledom savremene …

Introduction: Cardiovascular diseases are the leading cause of death both in Serbia and in
the rest of the world. It has been shown that as many as 80% of them are preventable …